Clinical trials: Acute Myocardial Infarction, completed
Acute Myocardial Infarction
Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI)
In the setting of reperfusion therapy in an acute myocardial infarction using primary percutaneous intervention (PCI), the body's own inflammatory system involving the complement cascade may be harmful.
- Trial name
- NCT00091637
- Testing
- Pexelizumab
- Where
- 349 sites in United States, Australia and 15 more
- Volunteers
- 5,745 people
- Sponsor
- Procter and Gamble
Platelet Aggregation During Acute Myocardial Infarction
DPP-4 Inhibitors and Acute Myocardial Infarction:Effects on Platelet Function
Cardiovascular events are the main cause of mortality in diabetic patients ,on the other hand,during an acute myocardial infarction(AMI),hyperglycemia increases mortality and is related to different pathophysiologic processes.
- Trial name
- NCT02377388
- Testing
- sitagliptin OR saxagliptin
- Where
- Brazil
- Volunteers
- 74 people
- Sponsor
- University of Sao Paulo General Hospital
Acute Myocardial Infarction, Congestive Heart Failure
Nicorandil Study to Reduce Cardiac Death After Percutaneous Coronary Intervention (PCI) in Hemodialysis Patients
Survival after invasive coronary revascularization is worse in patients with chronic kidney disease than in those without it. The investigators aimed to examine whether oral administration of nicorandil, a hybrid of nitrate and…
- Trial name
- NCT00848562
- Testing
- Nicorandil
- Where
- Japan
- Volunteers
- 129 people
- Sponsor
- Toujinkai Hospital
Acute Coronary Syndrome, Angina Pectoris
Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
Drug eluting stents (DES) are widely used for treatment of coronary artery lesions. The Xience Sierra stent has a refined design of the metal stent backbone and is used in patients with various clinical syndromes and in different…
- Conditions
- Acute Coronary Syndrome, Angina Pectoris, Angina, Unstable, Myocardial Infarction
- Trial name
- NCT04475380
- Testing
- Percutaneous coronary intervention
- Where
- 2 sites in Netherlands
- Volunteers
- 1,757 people
- Sponsor
- Foundation of Cardiovascular Research and Education Enschede
Myocardial Infarction
Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial Infarction
The purpose of this study is to see if a naturally-occurring hormone called erythropoietin changes the action of platelets in the blood.
- Trial name
- NCT00367991
- Testing
- Recombinant human erythropoietin alfa (drug)
- Where
- United States
- Volunteers
- 44 people
- Sponsor
- Yale University
Myocardial Infarction
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)
This is a study in adults who had a heart attack (myocardial infarction). The purpose of this study is to find out whether a medicine called empagliflozin helps to lower the chances of having to go to the hospital for heart…
- Trial name
- NCT04509674
- Testing
- Empagliflozin
- Where
- 439 sites in United States, Argentina and 20 more
- Volunteers
- 6,522 people
- Sponsor
- Boehringer Ingelheim
Myocardial Infarction, Acute, Myocardial Infarction First
MSCs for Prevention of MI-induced HF
Results from recent clinical trials on bone marrow mononuclear cell (BM-MNC) transplantation show that this intervention can help reduce the incidence of heart failure (HF) after acute myocardial infarction (AMI).
- Conditions
- Myocardial Infarction, Acute, Myocardial Infarction First, Myocardial Infarction, Anterior Wall, Cardiac Remodeling, Ventricular
- Trial name
- PREVENT-TAHA8 (NCT05043610)
- Testing
- Umbilical Cord-Derived Wharton's Jelly Mesenchymal Stem Cells (WJ-MSCs), Conventional Treatment
- Where
- 3 sites in Iran
- Volunteers
- 420 people
- Sponsor
- Shiraz University of Medical Sciences
ST Elevation Acute Myocardial Infarction
Does Cyclosporine ImpRove Clinical oUtcome in ST Elevation Myocardial Infarction Patients at 3 Years of Follow-up. CIRCUS II Study
Infarct size is a major determinant of vital prognosis after AMI. We recently reported that cyclosporine A, when administered immediately prior to PCI reperfusion, can significantly reduce infarct size in STEMI patients.
- Trial name
- CIRCUS II (NCT02934217)
- Testing
- Injection of Cyclosporin, Echocardiography
- Where
- France
- Volunteers
- 868 people
- Sponsor
- Hospices Civils de Lyon
Acute Myocardial Infarction
Is the 4MGS a Useful Outcome Measure Post-PPCI
This study aims to assess usual walking speed (4-metre gait speed) in patients undergoing primary percutaneous coronary intervention (PCI) for acute myocardial infarction and to assess whether this can predict future…
- Trial name
- NCT02261324
- Where
- United Kingdom
- Volunteers
- 560 people
- Sponsor
- Royal Brompton & Harefield NHS Foundation Trust
Acute Coronary Syndrome, Old Myocardial Infarction
Brilinta Clinical Experience Investigation
To confirm the following safety topics in patients to be treated with BRILINTA tablets 60 mg or 90 mg (hereinafter referred to as "BRILINTA") in clinical practice in the post-marketing phase. 1.
- Trial name
- BRLCEIACS/OMI (NCT03212287)
- Where
- 71 sites in Japan
- Volunteers
- 663 people
- Sponsor
- AstraZeneca
Angina, Unstable
Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Testing on Outcomes
In a randomized, controlled clinical trial, point-of care testing at the bedside using the cardiac biomarker troponin I in ED patients with possible ACS will be compared to traditional testing of this assay for myocardial…
- Trial name
- Dispo-ACS (NCT00222352)
- Testing
- Point of Care cTnL testing
- Where
- 4 sites in United States
- Volunteers
- 2,000 people
- Sponsor
- University of Cincinnati
Myocardial Infarction, Coronary Disease
The MI-HEART Project
The purpose of the study is to examine ways in which a clinical information system can help patients better recognize the signs and symptoms of an acute myocardial infarction (heart attack) and to take actions to decrease…
- Trial name
- NCT00013741
- Testing
- Tailored Education Messages
- Where
- United States
- Volunteers
- 55 people
- Sponsor
- National Library of Medicine (NLM)
Coronary Disease, Myocardial Infarction
Fluvastatin in the Therapy of Acute Coronary Syndrome
This study is to evaluate the safety and efficacy of fluvastatin versus placebo, dosed shortly after or immediately when the coronary event occurs.
- Trial name
- NCT00171275
- Testing
- Fluvastatin
- Where
- Czechia
- Volunteers
- 1,000 people
- Sponsor
- Novartis
Myocardial Infarction, Acute
Pharmacoinvasive Strategy vs. Primary PCI in STEMI: A Prospective Registry in a Large Geographical Area
For patients presenting with ST-elevation myocardial infarction (STEMI), immediate and timely reperfusion treatment is essential.
- Trial name
- PHASE-MX (NCT03974581)
- Testing
- Primary percutaneous coronary intervention, Pharmacoinvasive strategy
- Where
- Mexico
- Volunteers
- 500 people
- Sponsor
- Instituto Nacional de Cardiologia Ignacio Chavez
ST Elevation Myocardial Infarction
Coronary Physiology Testing in Acute Coronary Syndromes
This is an interventional, prospective, multicenter study (5 IRCCS hospitals belonging to the Italian Cardiology Network) in patients with STEMI treated with successful primary PCI to assess the ability of coronary physiology…
- Trial name
- CoPhyTea (NCT04677257)
- Testing
- PCI, invasive coronary physiology and CMR
- Where
- 5 sites in Italy
- Volunteers
- 130 people
- Sponsor
- IRCCS San Raffaele
Acute Myocardial Infarction, Coronary Artery Disease
Acute Coronary Syndrome and Nurse Counselling
The goal of this clinical trial is to examine in patients with acute coronary syndrome. The main questions it aims to answer are: Does nurse counseling affect quality of life? Does nurse counseling affect functional capacity?…
- Trial name
- NCT06034054
- Testing
- nursing counceling
- Where
- Turkey (Türkiye)
- Volunteers
- 66 people
- Sponsor
- Iskenderun State Hospital
Acute Myocardial Infarction
Copeptin Registry (proCORE) Biomarkers in Cardiology (BIC)-19
Registry of an interventional Study-proved Strategy (BIC-8) using Copeptin and Troponin for the Early Rule-Out of Acute Myocardial Infarction (AMI) in Patients with Suspected Acute Coronary Syndrome (ACS) and a low-to…
- Trial name
- proCORE (NCT02490969)
- Testing
- Routine management observation
- Where
- Germany
- Volunteers
- 2,256 people
- Sponsor
- Charite University, Berlin, Germany
Myocardial Infarction
A Study of Allogeneic Low Oxygen Mesenchymal Bone Marrow Cells in Subjects With Myocardial Infarction
The purpose of this study is to assess the safety, tolerability and preliminary efficacy of human allogeneic ischemia tolerant mesenchymal bone marrow cells (aLoOxMBMC) administered intravenously to subjects with Acute Myocardial…
- Trial name
- NCT02672267
- Testing
- Stem cells
- Where
- Kazakhstan
- Volunteers
- 50 people
- Sponsor
- Altaco XXI, LLP
Myocardial Infarction, Acute Coronary Syndrome
LPS and Platelet Activation in Myocardial Infarction
Platelets play a key role in the athero-thrombotic process. However, the in vivo mechanism accounting for thrombus growth at site of coronary atherosclerotic lesion has not been fully elucidated.
- Trial name
- NCT03675789
- Where
- Italy
- Volunteers
- 150 people
- Sponsor
- University of Roma La Sapienza
Myocardial Infarction
Safety of KAI-9803 for Injection With Angioplasty Following Heart Attack
Restoring blood flow to coronary arteries as quickly as possible is the best way to reduce the damage to the muscle that occurs with a heart attack.
- Trial name
- NCT00093197
- Testing
- KAI-9803 for Injection
- Where
- United States
- Volunteers
- 154 people
- Sponsor
- KAI Pharmaceuticals